Politics
Investing
Stocks
Business

Politics
Investing
Stocks
Business

Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025

May 12, 2025

Acceleration of RAD204 Phase 1 dose escalation trial

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Multiple New Multi-Commodity Targets

next post

House GOP unveils Medicaid work requirements in Trump’s ‘big, beautiful bill’

Related Posts

GTI Energy

July 28, 2025

Copper Soars to All-time High as Trump Unveils...

July 10, 2025

Golconda Gold

September 30, 2025

Coelacanth Announces Q4 2024 Financial and Operating Results

April 24, 2025

Top 5 Canadian Mining Stocks This Week: Adyton...

May 31, 2025

Editor’s Picks: Gold Hits New High, Silver Squeeze...

March 29, 2025

Murchison South Increases to 67koz Gold Across Two...

May 13, 2025

Seequent Unveils Evo: Using Open-source Tech to Reshape...

March 15, 2025

Munda Gold Mine Mining Progresses: First Blast

June 19, 2025

Homerun Resources

August 20, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Editors’ Picks

1

Copper Price Update: Q1 2025 in Review
April 14, 2025
2

The Best Five Sectors, #10
March 14, 2025
3

DP Trading Room: Market Sell-Off
March 14, 2025
4

5 Strong Stocks Defying the Bearish Market!
March 14, 2025
5

Sector Rotation Warning: More Downside Ahead for US Markets?
March 14, 2025
6

Transform Your Investing Strategy: Uncover the 3 Game-Changing Rules
March 14, 2025
7

Did Friday’s Reversal Mark A Major Bottom?
March 14, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 capitaladept.com | All Rights Reserved